Advanced Filters
noise

cancer-pediatric Clinical Trials

A listing of cancer-pediatric medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 188 clinical trials
E Elyse Park, PhD

Virtual Health Insurance Navigation Pilot Program for Childhood Survivors (HINTII)

The investigators are conducting a Type I hybrid effectiveness-implementation trial to assess the effectiveness of HINT-S (synchronous) compared to enhanced usual care (EUC) in promoting health insurance literacy, thus reducing worry, unmet health care needs, and financial consequences due to medical costs to improve care and long-term outcomes of childhood …

18 - 100 years of age Both Phase N/A
E Elias Dreismickenbecker

Exercise Training in Childhood Cancer

The purpose of this multicenter study is to evaluate a personalised and standardised exercise intervention for children and adolescents undergoing anti-cancer treatment.

4 - 21 years of age Both Phase N/A
D Do Hoon Lim, MD, PhD

Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy

The study aim of this study is to evaluate the effect of proton therapy on quality of life and long-term normal tissue toxicities of the pediatric cancer patients. Based on these results, the predictive model of long-term normal tissue toxicities, survival, and quality of life could be recognized. Risk-adapted treatment …

- 18 years of age Both Phase N/A
K Kelsey Gabel, PhD

Time Restricted Eating With or Without a Fiber Supplement for Weight Management in Pediatric Cancer Survivors

This study aims to address a critical gap in pediatric oncology survivorship care by exploring innovative solutions to addressing obesity and its comorbidities in pediatric cancer survivors. The majority (99%) of pediatric cancer survivors will develop severe chronic health conditions by age 50, with 96% developing at least one severe/disabling, …

18 - 39 years of age Both Phase N/A

Overnight Fasting After Completion of Therapy: The OnFACT Study

The purpose of this study is to test whether regularly not eating for at least 14 hours overnight ("intermittent fasting") is feasible and can improve blood sugar.

18 - 100 years of age Both Phase N/A
K Karsten Nyson, MD

European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors

This proof-of-concept platform trial is designed to cover the targeting of several survival pathways in oncogenesis that are currently not adequately employed for pediatric patients in Europe (Geoerger 2017; Geoerger 2019). The aims of the trial are: To determine the recommended phase II dose (RP2D) of a specific anticancer agent …

- 18 years of age Both Phase 1/2
W William Terry

SurvivorLink: Scalability of an Electronic Personal Health Record

Previous research suggests that children and adolescents with cancer are at heightened risk of late effects that can occur months or years after cancer treatment, yet little is known about programs that increase their return for follow-up cancer care and late effects surveillance. This study will evaluate the impact of …

- 100 years of age Both Phase N/A
F Frederic MILLOT, MD

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

Methodology Prospective, multicentric, open, non-randomised, non-therapeutic, interventional study

1 - 25 years of age Both Phase N/A
A Allen Yeoh, MBBS

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

To evaluate the outcome of a prednisolone and low dose methotrexate based protocol in Down syndrome children with ALL (DS-ALL) in an Asia-wide study. The treatment protocol was modified based upon backbone of Taiwan Pediatric Oncology Group (TPOG)-ALL protocol in which risk classification will be guided by level of flow …

- 20 years of age Both Phase 2
B Birgit Geoerger, MD

MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2

FMG2025 continues the previous efforts to propose treatment for patients based on the molecular characteristics of their tumor at treatment failure in cancer precision medicine trials within standard of care in France. However, whereas FMG2025 is a descriptive effort providing the basis for clinical decisions, MAPPYACTS 2 will translate these …

6 - 25 years of age Both Phase N/A

Rewrite in simple language using AI